What question did this study set out to answer?

To explore prognostic factors affecting survival in hepatocellular carcinoma after surgery and compare prognostic models.

May 8, 2026Open Access

Integrated clinicopathological model versus TNM for predicting survival in resected hepatocellular carcinoma: a retrospective cohort study

Key Points

To explore prognostic factors affecting survival in hepatocellular carcinoma after surgery and compare prognostic models.
Retrospective cohort study of 249 patients undergoing radical liver resection
Used Cox proportional hazards model to identify prognostic factors
Assessed model performance with C-index, ROC curves, DCA, and calibration plots.
Integrated model showed C-index of 0.676 compared to 0.647 for TNM alone
Time-dependent ROC analysis indicated higher AUC values for integrated model at 1 year (0.725), 3 years (0.703), and 5 years (0.684)
DCA showed greater net benefit for integrated model across thresholds, with good calibration.

Abstract

Abstract Objective To explore prognostic factors of postoperative hepatocellular carcinoma (HCC) and compare the prognostic performance of the tumor–node–metastasis (TNM) system with an integrated clinicopathological model. Methods We conducted a cohort study evaluating 249 patients with HCC who underwent radical liver resection between January 2015 and December 2024. Overall survival (OS) was the primary endpoint. Independent prognostic factors were determined using the Cox proportional hazards model. Model performance was assessed using the correlation index (C-index) with bootstrap internal validation. Time-dependent receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration plots were used to assess discrimination, clinical utility, and agreement between predicted and observed outcomes. Results In multivariable analysis, TNM stage, microvascular invasion (MVI), resection margin status, and albumin–bilirubin (ALBI) grade were independent predictors of OS. For recurrence-free survival (RFS), independent predictors included hepatitis status, ALBI grade, TNM stage, and MVI. The integrated model demonstrated improved discrimination compared with TNM alone, with a higher optimism-corrected C-index (0.676 vs. 0.647). Time-dependent ROC analysis showed significantly higher AUC values for the integrated model at 1 year (0.725 vs. 0.669, p = 0.046), 3 years (0.703 vs. 0.657, p = 0.024), and 5 years (0.684 vs. 0.649, p = 0.031). DCA indicated greater net benefit across clinically relevant thresholds, and calibration plots showed good agreement between predicted and observed survival probabilities. Conclusion An integrated clinicopathological model incorporating TNM stage, MVI, ALBI grade, and resection margin status improves prognostic performance compared with TNM alone in patients undergoing curative resection for HCC. This model may support more accurate postoperative risk stratification.

Bookmark

View Full Paper